Publication | Open Access
Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment
39
Citations
27
References
2020
Year
These novel preclinical data support initiation of a first-in-human clinical trial with this combination immunotherapy strategy in pancreatic cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1